Skip to main content
. 2023 Jul 6;5:1147628. doi: 10.3389/frph.2023.1147628

Table 2.

Selected characteristics of study participants at enrollment.

n = 25 %
Age in years [median (min - max)] 36 (21–43 years)
Hispanic or Latino 2 8
Race (mark all that apply)
Asian 2 8
Black or African American 3 12
White 20 80
Highest level of education level completed
High school graduate 4 16
Partial college 4 16
College graduate 8 32
Partial graduate school 3 12
Graduate school degree 6 24
Relationship Status
Not in a relationship, single 10 40
In a relationship, not married 8 32
Married 6 24
Divorced 1 4
Currently has a primary sex partner 15 60
Gender of primary sex partner (n = 15)
Man 13 87
Woman 1 7
Transgender man 1 7
Study product assignment
Continuous (One 90-day cycle) 12 48
Cyclic (Three 28-day cycles with two-day removals periods) 13 52
Prior use of contraceptive methods*
Male condom 25 100
Oral contraception 15 60
Emergency contraception 11 44
Contraceptive patch 3 12
Depot medroxyprogesterone acetate 6 24
Contraceptive/hormonal vaginal ring 4 16
Spermicidal sponge, foam, cream, or jelly 4 16
Intrauterine device 8 32
Implant 2 8
Withdrawal 16 64
Fertility awareness-based methods 9 36
Female sterilization 1 4
Male sterilization 3 12
Other [spermicidal suppository, assumption of male infertility] 2 8
Prior use of non-contraceptive vaginal products
Vaginal medication in cream or gel form 12 48
Douche/vaginally applied “hygiene” product 6 24
Tampon 24 96
Menstrual cup 10 40
Personal or sexual lubricant 17 68
Sex toys 15 60
Other [Water] 1 4

*All participants reported prior use of at least one contraceptive method. No participants reported exposure to the female or internal condom or cervical barriers.